期刊文献+

Design, Synthesis and Antifungal Activity of 6-Fluoro-3,3a,4,5-tetrahydro-2H-pyrazolo[4,3-c]-quinoline-2-carboxamide Derivatives

Design, Synthesis and Antifungal Activity of 6-Fluoro-3,3a,4,5-tetrahydro-2H-pyrazolo[4,3-c]-quinoline-2-carboxamide Derivatives
下载PDF
导出
摘要 A series of 6-fluoro-3,3a,4,5-tetrahydro-2H-pyrazolo[4,3-c]quinoline-2-carboxamide derivatives was designed based on the bioisosterism and combination principle in drug design. The target compounds were synthesized from substituted aniline through Michael addition, cyclization, Mannich reaction and condensation with 4-substituted semicarbazides, and the structures were confirmed by mass spectrometry(MS) and 1H NMR. The antifungal assay was carried out in vitro by two-fold dilution. The result shows that all the compounds are of antifungal activities against the tested fungi at different levels. A series of 6-fluoro-3,3a,4,5-tetrahydro-2H-pyrazolo[4,3-c]quinoline-2-carboxamide derivatives was designed based on the bioisosterism and combination principle in drug design. The target compounds were synthesized from substituted aniline through Michael addition, cyclization, Mannich reaction and condensation with 4-substituted semicarbazides, and the structures were confirmed by mass spectrometry(MS) and 1H NMR. The antifungal assay was carried out in vitro by two-fold dilution. The result shows that all the compounds are of antifungal activities against the tested fungi at different levels.
出处 《Chemical Research in Chinese Universities》 SCIE CAS CSCD 2011年第6期955-957,共3页 高等学校化学研究(英文版)
基金 Supported by the National Science and Technology Major Projects of China(No.2009ZX09301-012)
关键词 6-Fluoro-3 3a 4 5-tetrahydro-2H-pyrazolo[4 3-c]quinoline-2-carboxamide derivative Cysteine protease in-hibitor Antifungal activity 6-Fluoro-3 3a 4 5-tetrahydro-2H-pyrazolo[4 3-c]quinoline-2-carboxamide derivative Cysteine protease in-hibitor Antifungal activity
  • 相关文献

参考文献1

二级参考文献14

  • 1Zhang Y. , Sun X. W. , Hui X. P. , et al. , Chin. J. Chem. ,2002, 23, 168
  • 2Ernest H. , William J. H. , GB 2078212, 1982
  • 3Kenneth G. H. , Achytharao S. , Jefferson W. T. ,US 6423728, 2002
  • 4Walter H. , Schneider H. , EP 1252140, 2001
  • 5Magyar K. , Mezei T. , Nagy A., et al. , CN 1062728, 1992
  • 6Vera K. , Lenka Z. , Karel W. , et al. , Farmaco. , 2004,59(4), 279
  • 7Joanna M. , Andrzej N. , Elzbieta K. , et al. , Farmaco. , 2003,58(6), 455
  • 8Xu L. Z., Zhang S. S., Hu Z. Q., et al. , Chem. Res. Chinese Universities, 2003, 19(3), 310
  • 9Sheldrick G. M., SHELXTL97, Program for Crystal Structure Refinement, University of Gottingen, Germany, 1993
  • 10Wilson A. J., International Table for X-ray Crystallography.,Vol. C, Kluwer Academic Publisher, Dordrecht, 1992, Tables 6.1.1.4(p500) and 4.2.6.8(p219)

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部